Internal Medicine · Sierra Vista, AZ
NPI
1316960016
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1620 E Wilcox Dr
Sierra Vista, AZ, 85635
Phone (520) 459-0362
Groups this clinician bills Medicare through
Medicare paid, 2024
$567K
20,168 services
Medicare patients, 2024
1,016
Average age 76
Drug cost, 2024
$2.2M
15,714 prescriptions
Company payments, 2025
$384
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Santsaran C Patel was code J0897 (injection, denosumab, 1 mg), 9,060 times for 85 patients. In total Santsaran C Patel billed 20,168 services in 98 codes, and Medicare paid $567K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 9,060 | 85 | $17.69 | $160K |
| 99214 Office E&M - Established | Office | 2,299 | 784 | $79.94 | $184K |
| 99213 Office E&M - Established | Office | 815 | 424 | $54.58 | $44K |
| 96372 Injection Administration | Office | 795 | 214 | $9.00 | $7,152 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 573 | 573 | $119.94 | $69K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 434 | 82 | $0.68 | $294 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 423 | 72 | $0.86 | $363 |
| 99215 Office E&M - Established | Office | 391 | 250 | $116.29 | $45K |
| G0008 Administration of influenza virus vaccine | Office | 230 | 227 | $29.34 | $6,749 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 225 | 38 | $0.43 | $96.52 |
| 90653 Vaccine Product | Office | 166 | 166 | $81.82 | $14K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 149 | 15 | $0.35 | $51.63 |
| 95117 Treatment - Miscellaneous | Office | 134 | 14 | $6.97 | $934 |
| 83036 Blood Count | Office | 134 | 92 | $9.52 | $1,276 |
| 81002 Clinical Chemistry | Office | 105 | 73 | $3.41 | $358 |
By year: 2022 $636K for 18,213 services; 2023 $615K for 16,471 services; 2024 $567K for 20,168 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 134 | 92 | $9.52 | $1,276 |
| 81002 Clinical Chemistry | 105 | 73 | $3.41 | $358 |
| 85610 Clinical Chemistry | 53 | 12 | $4.20 | $223 |
| 87426 Immunoassay | 15 | 15 | $34.30 | $515 |
Medicare prescription drug claims, 2024
In 2024, the drug Santsaran C Patel prescribed most often to Medicare patients was Levothyroxine Sodium, with 724 prescriptions and refills. In total Santsaran C Patel wrote 15,714 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 724 | 1,959 | 208 | $7,900 |
| Atorvastatin Calcium Generic | 537 | 1,472 | 162 | $5,115 |
| Losartan Potassium Generic | 427 | 1,189 | 132 | $4,222 |
| Pantoprazole Sodium Generic | 427 | 1,057 | 127 | $4,422 |
| Gabapentin Generic | 424 | 745 | 121 | $5,871 |
| Rosuvastatin Calcium Generic | 383 | 1,084 | 121 | $5,194 |
| Escitalopram Oxalate Generic | 292 | 710 | 82 | $3,618 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 284 | 284 | 49 | $6,245 |
| Simvastatin Generic | 281 | 799 | 81 | $2,314 |
| Amlodipine Besylate Generic | 279 | 715 | 79 | $1,442 |
| Tramadol Hcl Generic | 262 | 280 | 54 | $1,443 |
| Metformin Hcl Generic | 254 | 551 | 67 | $1,300 |
| Furosemide Generic | 245 | 610 | 80 | $1,228 |
| Omeprazole Generic | 234 | 586 | 67 | $2,870 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 218 | 220 | 41 | $4,513 |
Brand drugs: 1,931 claims; generic drugs: 13,678 claims; opioid claims: 1,168.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Santsaran C Patel $384 ($384 in general payments such as food, travel and fees) from 10 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $77.68.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $77.68 |
| Amgen Inc. AMGN | 4 | $64.65 |
| Abbvie Inc. ABBV | 2 | $43.84 |
| Astellas Pharma US Inc 4503.T | 2 | $38.77 |
| Novo Nordisk Inc NVO | 2 | $37.78 |
| Lilly USA, LLC LLY | 2 | $33.23 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $27.13 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $22.25 |
| Abbott Laboratories ABT | 1 | $21.44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $16.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.